TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs May 30, 1980